How Common Is Thoracic Outlet Syndrome?
The incidence of neurogenic thoracic outlet syndrome is completely unknown, and has been wildly overestimated in the past. Based on a prospectively maintained database at our academic Thoracic Outlet Center,…
The incidence of neurogenic thoracic outlet syndrome is completely unknown, and has been wildly overestimated in the past. Based on a prospectively maintained database at our academic Thoracic Outlet Center,…
Cardiac Troponin (hs-TnT) elevation has been reported in unselected patients hospitalized with COVID-19 however the mechanism and relationship with mortality remain unclear. Consecutive patients admitted to a high-volume intensive care…
The COVID-19 pandemic disproportionately affects females in the home and workplace. This study aimed to acquire information regarding the gender-specific effects of the COVID-19 lockdown on aspects of professional and…
In patients with pulmonary artery hypertension (PAH) associated with atrial septal defect (ASD), closure of ASD may carry significant risks. We aimed to evaluate the safety and efficacy of transcatheter…
HIGHLIGHTS • Left ventricular stroke work index (LVSWi) and right ventricular stroke work index (RVSWi) independently predict mortality after transcatheter mitral valve repair (TMVR). • Patients with low LVSWi and…
The aim of this study was to assess differences in etiology, comorbidities, echocardiographic parameters, and prognosis between men and women with significant tricuspid regurgitation (TR). Clinical and echocardiographic characteristics of…
Breast cancer and cardiovascular-specific mortality are higher among blacks compared with whites, but disparities in cancer therapy-related adverse cardiovascular outcomes have not been well studied. We assessed for the contribution…
Highlights • Long-term data for patients undergoing TAVI with the first generation self-expanding bioprosthesis are consistent with low mortality rates and satisfying valve performance. • Really long-term clinical outcomes and…
There are limited data to support proposed increases to the minimum institutional mitral valve (MV) surgery volume required to begin a transcatheter mitral valve repair (TMVr) program. The current study…
• Thromboembolic events remain clinically resolved after TAVR. • DOAC use to reduce thrombosis associated with TAVR remains controversial. • Coagulation parameters were significantly increased after TAVR. • Hypercoagulation status…